Skip to search formSkip to main contentSkip to account menu

refractory cancer

Known as: clinical resistance, resistant cancer, cancer refractory 
Cancer that does not respond to treatment. The cancer may be resistant at the beginning of treatment, or it may become resistant during treatment.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
Aim: To determine the safe dose range and pharmacokinetics of metronomic oral vinorelbine and obtain preliminary data on… 
Review
2006
Review
2006
Galectins form a family of carbohydrate-binding proteins defined by their affinity for beta-galactosides containing… 
Highly Cited
2004
Highly Cited
2004
Procedure of the synthesis is described for new platinum(IV) drug LA-12 [(OC-6-43)-bis(acetato)(1-adamantylamine… 
Highly Cited
2001
Highly Cited
2001
Intrinsic or acquired resistance of tumor cells to multiple cytotoxic drugs (multidrug resistance MDR) is a major cause of… 
Review
2001
Review
2001
Imatinib (STI571, Glivec) is a small molecule drug selected for its ability to inhibit the Bcr-Abl kinase, the pathogenic… 
Highly Cited
1986
Highly Cited
1986
A total of 24 patients with intractable cancer pain were evaluated as candidates for spinal morphine therapy. Temporary trials…